ShoreGroup to design and
build an advanced strategic rich-media communication and collaboration platform
utilizing Cisco Unified Communications and WebEx
NEW YORK, NY. January 6, 2010 — ShoreGroup, Inc., a premier converged network and systems management solutions and IT professional services firm, today announced that the Juvenile Diabetes Research Foundation International (JDRF) has engaged ShoreGroup to design and deploy an enterprise communication solution that will increase employee productivity and foster efficient group collaboration between employees, volunteers, corporate sponsors and advocacy groups. With 112 chapters located throughout the United States, JDRF is the leader in research leading to better treatments and a cure for type 1 diabetes and its complications.
ShoreGroup will be providing JDRF with
the foundational architecture, comprised of a converged Cisco® IP infrastructure backbone
coupled with Cisco's most advanced Unified Communications applications, that will enable
JDRF to efficiently coordinate distribution of scientific updates and announcements, industry
and corporate partnerships, public service information, advocacy campaigns, and the latest
updates on the organization's national fundraising activities, including the
Ride to Cure Diabetes program.
"Our chapters and research partners
cross boundaries of time and geography and as such, our communications applications must elevate
the power of communications to the next level while being flexible enough to grow with our
organization," said James Szmak, Vice President and Chief Information Officer of JDRF.
"ShoreGroup consulted extensively with our IT staff to ensure complete understanding of
our business processes to find areas where technology would enhance overall productivity. By
bringing to the table a robust, resilient, scalable, and cost-effective solution that integrates
voice, video and data to provide anytime, anywhere access across our network, ShoreGroup has
designed a framework that not only will enable rich collaboration but will afford JDRF the
ability to leverage next-generation telepresence with high-definition video conferencing technology."
"Information and communication
technologies are transforming the way business is conducted. Technology-enabled business
transformation relies on a practical approach that ensures real results from the capabilities of new
systems and industry-best practices that are implemented," said Barry Katzman, ShoreGroup's
Director of Engineering. "The ultimate benefit of deploying IP and unified communications is
achieved when the new capabilities are integrated into applications and key business processes to
transform decision-making and employee interaction."
JDRF is deploying Cisco Unified Communications
Manager 7.1 with Cisco Unity Unified Messaging, along with Cisco MeetingPlace Express audio conferencing
to provide call control, messaging and conferencing capabilities over a resilient MPLS IP Backbone to
all JDRF chapters.
"JDRF is a shining example of how a
forward-thinking organization can use a collaboration strategy to improve productivity, workflow and
communication while lowering ongoing operational costs," said Jeff Ortolano, ShoreGroup's Regional
Sales Director. "ShoreGroup has always taken a big picture approach when evaluating and
designing solutions for our customers as evidenced in the scope and complexity of this initiative. We are
excited to be engaged in this transformation, and look forward to providing the collaboration technologies
and services that will empower JDRF in their research efforts toward finding a cure for type 1 diabetes
and its complications."
JDRF is also deploying the Cisco WebEx solution
for Web-based meetings with real-time face-to-face video conferencing. All JDRF employees will have a
webcam for on-demand video calls and collaboration sessions. The Private IP MPLS network infrastructure
is designed with the Quality of Service (QoS) and bandwidth-on-demand capabilities required to support
About ShoreGroup, Inc.
ShoreGroup delivers a complete
portfolio of industry-leading management applications, maintenance solutions,
professional services and products for unified communications networks. ShoreGroup
develops innovative management applications on its dynamic CaseSentry® platform,
eliminating the pitfalls of traditional management systems to enable IT, telecom and
contact center support organizations to easily and effectively manage availability,
performance, service levels and support processes for complex networked environments.
The company's ShorePatrol Remote Management Service delivers the high-quality
unified communications monitoring, maintenance and support that organizations rely upon
to ensure the availability of their vital business processes.
ShoreGroup's professional service
solutions provide leading consultation, design and implementation services for high-availability
networks. The company's expertise in unified communications including IP Telephony/VoIP and
IP contact centers, LAN/WAN, data center, telepresence, wireless and security produces manageable
solutions that optimize business processes, communications, employee productivity and accessibility
to enable organizations to derive the maximum business value from their information technology
investment. As a Cisco Gold Certified Partner with advanced specializations, ShoreGroup's service
portfolio is backed by solid industry credentials.
Cisco and Cisco Systems are registered trademarks of Cisco Systems, Inc. in the U.S. and certain other countries. ShoreGroup and ShorePatrol are trademarks, and CaseSentry is a registered trademark of ShoreGroup, Inc. All other marks are property of their respective owners.
JDRF is a leader in setting the agenda for
diabetes research worldwide, and is the largest charitable funder and advocate of type 1 research.
The mission of JDRF is to find a cure for diabetes and its complications through the support of
research. Type 1 diabetes is a disease which strikes children and adults suddenly and requires
multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin,
however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications
which may include kidney failure, blindness, heart disease, stroke, and amputation. Since its
founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than
$1.3 billion to diabetes research, including more than $156 million in FY2008. In FY2008 the
Foundation funded more than 1,000 centers, grants and fellowships in 22 countries.
Additional information about JDRF can be found at www.jdrf.org.
January 6, 2010
The ShoreGroup Building
460 West 35th Street
New York, NY 10001